Ligand’s First Quarter Financial Results to be Reported May 6th

Go back to Ligand’s First Quarter Financial Results to be Reported May 6th
LIGAND PHARMA (NASDAQ: LGND) Delayed: 309.25 --0 (-0%)
Previous Close $309.25    52 Week High $139.79 
Open $309.25    52 Week Low $82.07 
Day High $309.25    P/E 719.19 
Day Low $309.25    EPS $0.43 
Volume 1,292